Castle Biosciences, Inc. (CSTL)
20.15
-0.39
(-1.90%)
USD |
NASDAQ |
May 22, 16:00
20.00
-0.15
(-0.74%)
After-Hours: 20:00
Castle Biosciences EPS Diluted (Quarterly) : -0.4859 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.241 |
| Labcorp Holdings, Inc. | 3.351 |
| Psychemedics Corp. | -- |
| Fulgent Genetics, Inc. | -0.8039 |
| Guardant Health, Inc. | -0.8538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.52M |
| Revenue (Quarterly) | 83.68M |
| Total Expenses (Quarterly) | 98.20M |
| Enterprise Value | 386.19M |
| Gross Profit Margin (Quarterly) | 72.15% |
| Profit Margin (Quarterly) | -17.35% |
| Earnings Yield | -2.13% |
| Normalized Earnings Yield | -2.655 |